Enhanced oral bioavailability of breviscapine after encapsulation in a liposomal formulation

Pharmazie

Volumn 60, Issue 6, 2005, Pages 475-476

  Zhong, Haijun J ^a   Deng, Y J ^a   Yang, B H ^a   Li, C L ^a   Du, S ^a  

^a SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BREVISCAPINE; CHOLESTEROL; FLAVONE DERIVATIVE; LIPOSOME; PHOSPHATIDYLCHOLINE; SCOPARONE; UNCLASSIFIED DRUG;

ACCURACY; ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG FORMULATION; DRUG HALF LIFE; DRUG SOLUTION; ENCAPSULATION; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; MEAN RESIDENCE TIME; NONHUMAN; RAT; STUDENT T TEST;

ANIMALS; ANTICOAGULANTS; AREA UNDER CURVE; BIOLOGICAL AVAILABILITY; CHEMISTRY, PHARMACEUTICAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG CARRIERS; DRUG COMPOUNDING; FEMALE; FLAVONOIDS; LIPOSOMES; MALE; RATS; RATS, WISTAR; REPRODUCIBILITY OF RESULTS; SPECTROPHOTOMETRY, ULTRAVIOLET;

EID: 22044434439     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Batzri S, Korn ED (1973) Single bilayer liposomes prepared without sonication. Biochem Biophys Acta 298: 1015-1019.
2. Chen XQ, Jin YY (1997) Breviscapine. In: Chen XQ (ed.) The New Edition of Medicaments, 14th ed., Beijing, p. 277-278.
3. Gruber P, Longer BH, Robinson JR (1987) Some biological issues in oral, controlled drug delivery. Adv Drug Deliv Rev 1: 1-18.
4. Guo J, Ping Q, Chen Y (2001) Pharmacokinetic behavior of cyclosporin A in rabbits by oral administration of lecithin vesicle and Sandimmun Neoral. Int J Pharm 216: 17-21.
5. Hassan Z, Nilsson C, Hassan M (1998) Liposomal busulphan: bioavailability and effect on bone marrow in mice. Bone Marrow Transplant 22: 913-918.
6. Kisel MA, Kulik LN, Tsybovsky IS, Vlasov AP, Vorob'yov MS, Kholodova EA, Zabarovskaya ZV (2001) Liposomes with phosphatidylethanol as a carrier for oral delivery of insulin: studies in the rat Int J Pharm 216: 105-114.
7. Lian T, Ho RJY (2001) Trend and developments in liposome drug delivery systems. J Pharm Sci 90: 667-680.
8. Naeff R (1996) Feasibility of topical liposome drugs produced on an industrial scale. Adv Drug Deliv Rev 18: 343-347.
9. Pons M, Foradada M, Estelrich J (1993) Liposomes obtained by the ethanol injection method. Int J Pharm 95: 51-56.
10. Rogers JA, Anderson KE (1998) The potential of liposomes in oral drug delivery. Crit Rev Ther Drug Carrier Syst 15: 421-480.
11. Wagner A, Vorauer-Uhl K, Kreismayr G, Katinger H (2002) The crossflow injection technique: an improvement of the ethanol injection method. J Liposome Res 12: 259-270.
12. Wang GX (1999) Advances on pharmacological research and clinical application of breviscapine. Lishizhen Medicine Mater Medica Res 10: 303-304.
13. Woodley JF (1985) Liposomes for oral administration of drugs. Crit Rev Ther Drug Carrier Syst 2: 1-18.
14. Zhong DF, Yang BH, Chen XY, Li K, Xu JH (2003) Determination of scutellarin in rat plasma by high-performance liquid chromatography with ultraviolet detection. J Chromatogr B 796: 439-444.